Adverse events3,390

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 3,390

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anemia	Blood and lymphatic system disorders	Block 1 Induction Therapy	5	661	5
other	Anemia	Blood and lymphatic system disorders	Arm A (HR and IR Control)	70	109	134
other	Anemia	Blood and lymphatic system disorders	Arm B (HR and IR Blinatumomab)	82	107	124
other	Anemia	Blood and lymphatic system disorders	Arm C (LR Control)	86	129	207
other	Anemia	Blood and lymphatic system disorders	Arm D (LR Blinatumomab)	95	127	236
other	Anemia	Blood and lymphatic system disorders	Blinatumomab Salvarage Therapy	20	27	33
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Block 1 Induction Therapy	1	661	1
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm A (HR and IR Control)	2	109	3
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm B (HR and IR Blinatumomab)	1	107	1
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm C (LR Control)	4	129	6
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Arm D (LR Blinatumomab)	2	127	2
other	Blood and lymphatic system disorders - Other, specify	Blood and lymphatic system disorders	Blinatumomab Salvarage Therapy	1	27	4
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Block 1 Induction Therapy	2	661	2
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Arm A (HR and IR Control)	1	109	1
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Arm B (HR and IR Blinatumomab)	1	107	1
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Arm C (LR Control)	0	129	0
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Arm D (LR Blinatumomab)	0	127	0
other	Disseminated intravascular coagulation	Blood and lymphatic system disorders	Blinatumomab Salvarage Therapy	0	27	0
other	Febrile neutropenia	Blood and lymphatic system disorders	Block 1 Induction Therapy	191	661	204
other	Febrile neutropenia	Blood and lymphatic system disorders	Arm A (HR and IR Control)	55	109	71

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02101853/events

API reference For AI assistants

Adverse events3,390

Sources 3

Read this list from software.